These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8326793)

  • 1. [Bone metabolism and thyroid disease. Normalized bone metabolism prevents osteoporosis].
    Tørring O
    Lakartidningen; 1993 Jul; 90(28-29):2517-21. PubMed ID: 8326793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Osteoporosis in thyroid diseases].
    Kosińska A; Syrenicz A; Kosiński B; Garanty-Bogacka B; Syrenicz M; Gromniak E
    Endokrynol Pol; 2005; 56(2):185-93. PubMed ID: 16335687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal osteoporosis and alendronate.
    Pérez-López FR
    Maturitas; 2004 Jul; 48(3):179-92. PubMed ID: 15207883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis prevention and treatment: its relevance to breast cancer patients.
    Hodsman AB
    Can J Oncol; 1995 Dec; 5 Suppl 1():28-32. PubMed ID: 8853521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postmenopausal osteoporosis: risk factors and possible therapies].
    D'Amore M; Minenna G; D'Amore S
    Minerva Med; 2003 Jun; 94(3):141-55. PubMed ID: 14605595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Bone markers"--when can they be useful?].
    Skjøstad JB
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3228-9. PubMed ID: 9411863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteoporosis in postmenopausal women].
    Orimo H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):785-90. PubMed ID: 2230411
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women.
    Harkness LS; Fiedler K; Sehgal AR; Oravec D; Lerner E
    J Womens Health (Larchmt); 2004 Nov; 13(9):1000-7. PubMed ID: 15665657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
    La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
    Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteoporosis. Current advances in etiopathogenesis, diagnosis and therapy. I.--Etiopathogenesis and diagnosis].
    Cotrozzi G; Relli P
    Clin Ter; 1994 Mar; 144(3):251-63. PubMed ID: 8181222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapies for the prevention or treatment of postmenopausal osteoporosis.
    Sato M; Grese TA; Dodge JA; Bryant HU; Turner CH
    J Med Chem; 1999 Jan; 42(1):1-24. PubMed ID: 9888829
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary prevention of osteoporosis: pediatric approach to disease of the elderly.
    Ilich JZ; Badenhop NE; Matkovic V
    Womens Health Issues; 1996; 6(4):194-203. PubMed ID: 8754669
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Med Lett Drugs Ther; 2000 Oct; 42(1090):97-100. PubMed ID: 11035622
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alendronate also for women without established osteoporosis?].
    Klovning A; Norheim OF
    Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1347-51. PubMed ID: 10868100
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis].
    Zatońska K; Bolanowski M
    Pol Merkur Lekarski; 2000 May; 8(47):356-9. PubMed ID: 10944962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SERM and quality of bone].
    Sohen S
    Clin Calcium; 2004 Oct; 14(10):96-9. PubMed ID: 15577138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical thyroid dysfunction.
    Woeber KA
    Arch Intern Med; 1997 May; 157(10):1065-8. PubMed ID: 9164371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.